Clearside Biomedical Inc. (CLSD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM

Clearside Biomedical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
20.02M 28.92M 48.26M 30.44M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 30K 160K
Other Long-Term Assets
30K 30K 1.14M n/a
Receivables
507K 170K n/a 10M
Inventory
n/a n/a n/a 921K
Other Current Assets
13K 311K 439K 779K
Total Current Assets
21.27M 30.12M 48.26M 42.14M
Property-Plant & Equipment
3.82M 3.87M 1.87M 607K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.85M 3.9M 3.04M 767K
Total Assets
25.13M 34.02M 51.3M 42.9M
Account Payables
1.45M 2.21M 1.05M 941K
Deferred Revenue
n/a 75K 205K n/a
Short-Term Debt
375K n/a 349K 387K
Other Current Liabilities
808K 1.86M 1.99M 1.47M
Total Current Liabilities
4.79M 6.81M 5.78M 4.64M
Long-Term Debt
328K 41.99M n/a n/a
Other Long-Term Liabilities
58.86M 480K 33.98M n/a
Total Long-Term Liabilities
59.19M 43.12M 33.98M 288K
Total Liabilities
63.98M 49.93M 40.7M 4.93M
Total Debt
703K 43M 1.28M 675K
Common Stock
77K 63K 61K 60K
Retained Earnings
-355.27M -320.92M -288.44M -255.49M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
-38.85M -15.91M 10.61M 37.98M
Total Investments
n/a n/a 30K 160K